| Literature DB >> 27317788 |
A Tanaka1, Y Yoshimura2, K Aoki1, M Kito1, M Okamoto1, S Suzuki1, T Momose1, H Kato1.
Abstract
OBJECTIVES: Our objective was to predict the knee extension strength and post-operative function in quadriceps resection for soft-tissue sarcoma of the thigh.Entities:
Keywords: Muscle strength; Post-operative function; Prediction; Quadriceps muscle; Soft-tissue sarcoma
Year: 2016 PMID: 27317788 PMCID: PMC4921041 DOI: 10.1302/2046-3758.56.2000631
Source DB: PubMed Journal: Bone Joint Res ISSN: 2046-3758 Impact factor: 5.853
Details of 18 patients with quadriceps resection for soft-tissue sarcoma of the thigh
| Patient number | Gender | Age (yrs) | Follow-up period (mths) | Tumour site | Maximum tumour diameter (mm) | Resected muscles | Quadriceps resections (n) | Extension strength (%) | MSTS score (%) | TESS(%) | EQ-5D(pts) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 66 | 123 | distal | 120 | VL,TFL,BL,BS | 1 | 91.3 | 100 | 100 | 1.000 |
| 2 | M | 85 | 19 | proximal | 114 | RF,IP,S,TFL | 1 | 89.7 | 86.7 | 93.7 | 1.000 |
| 3 | M | 60 | 136 | distal | 60 | VM | 1 | 82.9 | 100 | 100 | 1.000 |
| 4 | M | 74 | 85 | distal | 200 | VI | 1 | 69.9 | 93.3 | 75.9 | 0.691 |
| 5 | F | 57 | 18 | proximal | 113 | RF | 1 | 79.4 | 100 | 100 | 1.000 |
| 6 | F | 66 | 60 | distal | 60 | VM | 1 | 91.2 | 86.7 | 99.1 | 0.769 |
| 7 | M | 75 | 45 | distal | 56 | VL,VI1/2 | 1.5 | 52.6 | 70.0 | 60.6 | 0.516 |
| 8 | M | 63 | 34 | distal | 81 | VM,VI1/2,S | 1.5 | 65.2 | 100 | 100 | 1.000 |
| 9 | M | 60 | 80 | proximal | 78 | VL,VI1/2,TFL | 1.5 | 52.2 | 86.7 | 72.0 | 0.656 |
| 10 | M | 34 | 124 | distal | 50 | RF,VL1/2 | 1.5 | 56.2 | 90.0 | 90.1 | 0.850 |
| 11 | F | 59 | 21 | proximal | 94 | RF1/2,VL,TFL | 1.5 | 32.6 | 50.0 | 89.8 | 0.796 |
| 12 | M | 34 | 19 | distal | 61 | VM,VI1/2 | 1.5 | 71.7 | 96.7 | 100 | 0.796 |
| 13 | M | 76 | 12 | proximal | 132 | RF,VL1/2,GMe1/2,S,TFL | 1.5 | 60.0 | 73.3 | 80.0 | 0.691 |
| 14 | M | 61 | 74 | proximal | 107 | RF,VL | 2 | 58.4 | 96.7 | 98.2 | 1.000 |
| 15 | M | 74 | 47 | proximal | 110 | RF,VM,VI1/2, S,G,AM,AL,AB | 2.5 | 53.3 | 70.0 | 62.5 | 0.533 |
| 16 | F | 73 | 73 | middle | 140 | VM,VL,VI,TFL | 3 | 24.8 | 53.3 | 86.1 | 0.631 |
| 17 | M | 57 | 15 | proximal | 150 | RF,VM,VL,VI,S,TFL | 4 | 0 | 73.3 | 75.0 | 0.693 |
| 18 | M | 50 | 12 | proximal | 100 | RF,VL1/2,VI2/3,FN,IP,S | 4 (FN) | 0 | 73.3 | 78.3 | 0.587 |
VL, vastus lateralis; TFL, tensor fasciae latae; BL, biceps femoris long head; BS, biceps femoris short head; RF, rectus femoris; IP, iliopsoas; S, sartorius; VM, vastus medialis; VI, vastus intermedius; GMe, gluteus medius; G, gracilis; AM, adductor magnus; AL, adductor longus; AB, adductor brevis; FN, femoral nerve; MSTS, Musculoskeletal Tumor Society; TESS, Toronto Extremity Salvage Score; EQ-5D, European Quality of Life-5 Dimensions
Pathology type and adjuvant therapy
| Patient number | Pathology type | Chemotherapy | Radiation therapy | Time from final adjuvant therapy to measurement (mths) |
|---|---|---|---|---|
| 1 | Malignant fibrous histiocytoma | + | + | 121 |
| 2 | Pleomorphic liposarcoma | - | - | |
| 3 | Malignant fibrous histiocytoma | + | - | 85 |
| 4 | Dedifferentiated liposarcoma | - | + | 83 |
| 5 | Liposarcoma | - | - | |
| 6 | Low-grade fibromyxoid sarcoma | - | - | |
| 7 | Synovial sarcoma | - | - | |
| 8 | Inflammatory myofibroblastic sarcoma | - | - | |
| 9 | Myxofibrosarcoma | + | - | 37 |
| 10 | Malignant peripheral nerve sheath tumour | + | + | 98 |
| 11 | Undifferentiated pleomorphic sarcoma | + | + | 20 |
| 12 | Undifferentiated pleomorphic sarcoma | + | - | 16 |
| 13 | Myxofibrosarcoma | - | - | |
| 14 | Myxofibrosarcoma | - | - | |
| 15 | Myxofibrosarcoma | - | - | |
| 16 | Malignant fibrous histiocytoma | - | - | |
| 17 | Dedifferentiated liposarcoma | - | + | 15 |
| 18 | Myxoid liposarcoma | - | - |
Fig. 1Extension strength by number of resected muscles. Dots denote median extension strength values. The solid line shows the significant difference between the resection of one and 1.5 muscles (Mann-Whitney test, *p = 0.004). The horizontal line shows the cutoff value for extension strength (56.2%) at which acceptable results can be obtained. Strength at least equivalent to the cutoff value was observed with resection of up to 2.5 muscles.
Correlation between extension strength and various parameters by Spearman’s test
| Correlation coefficient | p-value | |
|---|---|---|
| Resection (n) | -0.87 | < 0.001[ |
| Maximum tumour diameter | -0.08 | 0.730 |
| Functional assessment scores | ||
| MSTS score | 0.70 | 0.004[ |
| TESS | 0.68 | 0.005[ |
| EQ-5D | 0.66 | 0.006[ |
Statistically significant difference
MSTS, Musculoskeletal Tumor Society; TESS, Toronto Extremity Salvage Score; EQ-5D, European Quality of Life-5 Dimensions
Correlation between extension strength and Toronto Extremity Salvage Score (TESS) items by Spearman’s test
| TESS items | |
|---|---|
| 1) Putting on a pair of pants[ | 16) Walking downstairs[ |
| 2) Putting on shoes[ | 17) Driving[ |
| 3) Putting on socks or stockings[ | 18) Walking within the house |
| 4) Showering | 19) Walking outdoors[ |
| 5) Light household chores | 20) Sitting |
| 6) Gardening and yard work[ | 21) Walking up or down hills or a ramp[ |
| 7) Preparing and serving meals[ | 22) Standing upright |
| 8) Going shopping[ | 23) Getting up from kneeling[ |
| 9) Heavy household chores[ | 24) Getting in and out of a car[ |
| 10) Getting in and out of the bath tub[ | 25) Participating in sexual activities |
| 11) Getting out of bed[ | 26) Completing my usual duties at work[ |
| 12) Rising from a chair[ | 27) Working my usual number of hours |
| 13) Kneeling[ | 28) Participating in my usual leisure activities[ |
| 14) Bending to pick something up off the floor[ | 29) Socialising with friends and family |
| 15) Walking upstairs[ | 30) Participating in my usual sporting activities |
Statistically significant difference
Correlation between extension strength and Short Form 8 parameters by Spearman’s test
| Median point (IQR) | Correlation coefficient | p-value | |
|---|---|---|---|
| PF | 41.5 (41.5 to 53.5) | 0.50 | 0.038[ |
| RP | 47.4 (40.7 to 54.1) | 0.47 | 0.055 |
| BP | 46.1 (46.1 to 58.4) | 0.44 | 0.071 |
| GH | 50.3 (50.3 to 50.3) | 0.19 | 0.419 |
| VT | 53.7 (44.5 to 53.7) | 0.02 | 0.946 |
| SF | 55.1 (45.6 to 55.1) | 0.16 | 0.514 |
| RE | 54.2 (43.7 to 54.2) | 0.26 | 0.281 |
| MH | 50.7 (44.9 to 56.9) | 0.32 | 0.184 |
| PCS | 42.9 (42.3 to 52.1) | 0.45 | 0.062 |
| MCS | 52.7 (45.8 to 55.9) | 0.02 | 0.172 |
Statistically significant difference
PF, physical functioning; RP, role physical; BP, bodily pain; GH, general health perceptions; VT, vitality; SF, social functioning; RE, role emotional; MH, mental health; PCS, physical component summary; MCS, mental component summary
The cutoff value of extension strength to expect good post-operative results by receiver operating characteristic curve, Fisher’s exact test
| MSTS score | TESS | EQ-5D | |
|---|---|---|---|
| Cutoff value of extension strength (%) | 56.2 | 56.2 | 56.2 |
| Sensitivity (%) | 90.9 | 81.8 | 100 |
| Specificity (%) | 100 | 85.7 | 63.6 |
| Area under the curve | 0.96 | 0.83 | 0.81 |
| p-value | < 0.001 | 0.009 | 0.004 |
Statistically significant difference
MSTS, Musculoskeletal Tumor Society; TESS, Toronto Extremity Salvage Score; EQ-5D, European Quality of Life-5 Dimensions